Lite Strategy LITS
NASDAQ LITS
$1.16 +0.01 (+0.87%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Operating Interest Expenses (2011)

Updated

Lite Strategy (LITS) posted Operating Interest Expenses of $406,000 for FY2012 (year ended Jun 30, 2012).

Analysis

Lite Strategy (LITS) Operating Interest Expenses (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn -
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn -
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn -
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Lite Strategy 40.09 Mn 7.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 9,000.00
Sep 30, 2011 397,000.00
API Access

Lite Strategy Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=LITS&period=max&api_key=YOUR_API_KEY